AYTU BIOPHARMA, INC Common Stock, Value, Issued
AYTU BIOPHARMA, INC (AYTU) had Common Stock, Value, Issued of $1.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-09-22
- 2026-06-30: Common Stock, Value, Issued $1.00K.
- 2026-03-31: Common Stock, Value, Issued $1.00K.
- 2025-12-31: Common Stock, Value, Issued $1.00K.
- 2025-09-30: Common Stock, Value, Issued $1.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $1.00K 10-K · filed 2026-09-22 | |
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.00K 10-Q · filed 2026-02-03 | |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.00K 10-K · filed 2026-09-22 | |
| 2025-03-31 | $1.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.00K 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.00K 10-K · filed 2025-09-23 | |
| 2024-03-31 | $1.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.00K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.00K 10-K · filed 2024-09-26 | |
| 2022-09-30 | $6.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.00K 10-Q · filed 2022-11-14 | |
| 2022-03-31 | $3.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $3.00K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $3.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $3.00K 10-K · filed 2022-09-27 | |
| 2021-03-31 | $2.35K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.79K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $12.58K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.00K 10-K · filed 2021-09-28 | $12.58K 10-K · filed 2020-10-06 |
| 2020-03-31 | $10.06K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.07K 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $1.80K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.75K 10-K · filed 2020-10-06 | |
| 2019-03-31 | $1.28K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.05K 10-Q · filed 2019-05-14 | |
| 2018-09-30 | $180.00 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $179.00 10-K · filed 2019-09-26 | |
| 2018-03-31 | $3.58K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $489.00 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $422.00 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $4.00 10-K · filed 2018-09-06 | $82.00 10-K · filed 2017-08-31 |
| 2017-03-31 | $1.38K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.08K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $511.00 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $19.00 10-K · filed 2017-08-31 | $374.00 10-K · filed 2016-09-01 |
| 2016-03-31 | $2.25K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $1.43K 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $1.43K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $119.00 10-K · filed 2016-09-01 | $1.43K 10-K · filed 2015-09-28 |
| 2015-03-31 | $4.46K 10-Q · filed 2015-05-19 | |
| 2015-02-28 | $554.73K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | $554.73K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | $539.73K 10-Q · filed 2015-04-15 | |
| 2014-06-30 | $790.00 10-K · filed 2015-09-28 | $4.46K 10-Q · filed 2015-05-19 |
| 2014-05-31 | $539.73K 10-Q · filed 2014-07-10 | |
| 2014-02-28 | $417.03K 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $417.03K 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $414.03K 10-K · filed 2014-11-26 | |
| 2013-05-31 | $412.03K 10-Q · filed 2013-06-28 | |
| 2013-02-28 | $412.03K 10-Q · filed 2013-04-15 | |
| 2012-11-30 | $412.03K 10-Q · filed 2013-01-14 | |
| 2012-08-31 | $407.03K 10-K · filed 2014-11-26 | |
| 2012-05-31 | $407.03K 10-Q · filed 2012-06-26 | |
| 2012-02-29 | $400.80K 10-Q · filed 2012-04-12 | |
| 2011-11-30 | $394.80K 10-Q · filed 2011-12-23 | |
| 2011-08-31 | $388.81K 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |